Test of choice to identify myocardial viability in ischemic cardiomyopathy.

被引：0
|
作者：
Vilacosta, I [1 ]
Vilacosta, I [1 ]
Hernandez, M [1 ]
Fernandez, C [1 ]
Merono, E [1 ]
Perez, MJ [1 ]
Montz, R [1 ]
SanRoman, JA [1 ]
SanchezHarguindey, L [1 ]
Carreras, JL [1 ]
机构：
[1] HOSP UNIV SAN CARLOS, MADRID, SPAIN
来源：
CIRCULATION | 1997年 / 96卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：499 / 499
页数：1
相关论文
共 50 条
  • [31] Electromechanical mapping for detecting myocardial viability and ischemia in patients with severe ischemic cardiomyopathy
    Samady, H
    Liu, YH
    Choi, CJ
    Ragosta, M
    Pfau, SE
    Cleman, MW
    Powers, ER
    Kramer, CM
    Wackers, FJT
    Beller, GA
    Watson, DD
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (07): : 807 - 811
  • [32] Myocardial Viability in Chronic Ischemic Cardiomyopathy: Similarities and Discordance of Different Diagnostic Approaches
    Weissman, Gaby
    Asch, Federico M.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2009, 2 (01) : 24 - 29
  • [33] Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy
    Auerbach, MA
    Schöder, H
    Hoh, C
    Gambhir, SS
    Yaghoubi, S
    Sayre, JW
    Silverman, D
    Phelps, ME
    Schelbert, HR
    Czernin, J
    CIRCULATION, 1999, 99 (22) : 2921 - 2926
  • [34] Giant thrombi in the left ventricle of a patient with ischemic cardiomyopathy.
    Bikkina, M
    Shakoor, A
    Massey, CV
    Alpert, MA
    Nikas, D
    Mukerji, V
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (01) : A4 - A4
  • [35] Assessment of Myocardial Viability in Ischemic Cardiomyopathy-Scarred by the Data but Still Alive
    Panza, Julio A.
    JAMA CARDIOLOGY, 2023,
  • [36] Quantification of myocardial fibrosis in hypertrophic cardiomyopathy. Interstudy reproducibility
    O' Hanlon, R.
    Grasso, A.
    Bucciarelli-Ducci, C.
    Wage, R.
    Kulkarni, M.
    Alsafi, A.
    Gatehouse, P.
    Roughton, M.
    Pennell, D. J.
    Prasad, S. K.
    EUROPEAN HEART JOURNAL, 2008, 29 : 55 - 55
  • [37] Myocardial scarring in minimally symptomatic patients with hypertrophic cardiomyopathy.
    Choudhury, L
    Mahrholdt, H
    Wagner, A
    Eliott, MD
    Choi, KM
    Vargas, JM
    Bonow, RO
    Judd, RM
    Kim, RJ
    CIRCULATION, 2001, 104 (17) : 757 - 757
  • [38] Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy -: Response
    Czernin, J
    Auerbach, MA
    Schöder, H
    Hoh, C
    Gambhir, SS
    Yaghoubi, S
    Sayre, JW
    Silverman, D
    Phelps, ME
    Schelbert, HR
    CIRCULATION, 2000, 102 (04) : E31 - E31
  • [39] MYOCARDIAL PERFUSION AND VIABILITY IN ISCHEMIC OR DILATED CARDIOMYOPATHY PATIENTS UNDERGOING HEART-TRANSPLANT
    DEMARIA, R
    PARODI, O
    TESTA, R
    SAMBUCETI, G
    OLTRONA, L
    ROGHI, A
    CATTANI, C
    PELLEGRINI, A
    ACCINNI, R
    BAROLDI, G
    CIRCULATION, 1992, 86 (04) : 371 - 371
  • [40] Cardiovascular magnetic resonance myocardial feature tracking for quantitative viability assessment in ischemic cardiomyopathy
    Schuster, Andreas
    Paul, Matthias
    Bettencourt, Nuno
    Morton, Geraint
    Chiribiri, Amedeo
    Ishida, Masaki
    Hussain, Shazia
    Jogiya, Roy
    Kutty, Shelby
    Bigalke, Boris
    Perera, Divaka
    Nagel, Eike
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 166 (02) : 413 - 420
12345